Marianne De Backer, Vir Biotechnology CEO
'Have to keep up this pace': As new Vir CEO, Marianne De Backer eyes expansion beyond infectious disease
On day two in the CEO seat at Vir Biotechnology, Marianne De Backer — a prolific, two-decade dealmaker in biopharma — said she’s ready to move fast …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
